April Cox
Impact in
- Pathology and Forensic Medicine top 10%
- Spinal Cord Injury Research
Papers in
-
- Spinal Cord Injury Research 7
-
- S100 Proteins and Annexins 3
- Ubiquitin and proteasome pathways 2
- Co-authors
- Naren L. Banik (8 shared papers)Azizul Haque (5 shared papers)Abhay Varma (3 shared papers)Swapan K. Ray (1 shared paper)Gary W. Arendash (2 shared papers)Alexey Vertegel (3 shared papers)Donald C. Shields (3 shared papers)Denise Matzelle (3 shared papers)
- Journals
- Neurochemical Research (3 papers)Blood (2 papers)Journal of Neurotrauma (2 papers)Molecular Neurobiology (1 paper)Frontiers in Endocrinology (1 paper)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
April Cox
16 papers receiving 491 citations
Peers
Comparison fields: 5 of 83
- Pathology and Forensic Medicine 138
- Developmental Neuroscience 29
- Cellular and Molecular Neuroscience 126
- Neurology 53
- Neurology 92
Countries citing papers authored by April Cox
This map shows the geographic impact of April Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April Cox more than expected).
Fields of papers citing papers by April Cox
This network shows the impact of papers produced by April Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April Cox. The network helps show where April Cox may publish in the future.
Co-authors
The 25 scholars most cited alongside April Cox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 90 | |
| 2 | 2006 | 63 | |
| 3 | ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models. | 2009 | 51 |
| 4 | 2015 | 46 | |
| 5 | 2014 | 43 | |
| 6 | 2017 | 41 | |
| 7 | 2015 | 40 | |
| 8 | 2017 | 35 | |
| 9 | 2020 | 24 | |
| 10 | 2009 | 18 | |
| 11 | 2021 | 16 | |
| 12 | 2015 | 11 | |
| 13 | ARRY-520, a KSP inhibitor with efficacy and pharmacodynamic activity in animal models of solid tumors | 2007 | 9 |
| 14 | 2013 | 5 | |
| 15 | 2009 | 4 | |
| 16 | 2008 | 1 | |
| 17 | 2008 | 1 |
About April Cox
April Cox is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Cellular and Molecular Neuroscience, Neurology and Cell Biology, having authored 17 papers that have together received 498 indexed citations. Recurring topics across this work include Spinal Cord Injury Research (7 papers), Nerve injury and regeneration (5 papers), S100 Proteins and Annexins (3 papers), Microtubule and mitosis dynamics (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers), Anesthesia and Neurotoxicity Research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (138 citations), Developmental Neuroscience (29 citations), Cellular and Molecular Neuroscience (126 citations), Neurology (53 citations) and Neurology (92 citations). April Cox has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Naren L. Banik, Azizul Haque, Abhay Varma, Swapan K. Ray, Gary W. Arendash, Alexey Vertegel, Donald C. Shields, Denise Matzelle, Zhiming Suo and Richard T. Premont. Their work appears in journals such as Neurochemical Research, Blood, Journal of Neurotrauma, Molecular Neurobiology and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.